Inactive Instrument
Aradigm Corporation Stock OTC Bulletin Board
Stocks
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 4.89M 4.27M 3.92M 3.66M 6.94M 465M 7.04M 47.12M 18.32M 229M 18.34M 17.94M 788M | P/E 2016 |
-0.72x | P/E 2017 | -9.3x |
|---|---|---|---|---|---|
| Enterprise Value | 12.8M 11.19M 10.28M 9.58M 18.18M 1.22B 18.45M 123M 47.99M 599M 48.04M 47.01M 2.06B | EV / Sales 2016 |
73.3x | EV / Sales 2017 | 7.27x |
| Free-Float |
60.28% | Yield 2016 * |
-
| Yield 2017 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 702K | |
| +1.70% | +7.41% | +2.50% | +8.22% | 49.92B | |
| +0.92% | +3.93% | +399.71% | +605.33% | 40.23B | |
| +1.89% | +8.32% | +26.06% | -6.35% | 34.55B | |
| +2.38% | +6.35% | +21.25% | +64.58% | 33.09B | |
| +3.96% | +10.67% | +8.30% | +40.44% | 27.51B | |
| +2.51% | +5.27% | - | - | 17.05B | |
| +2.58% | +5.79% | +73.44% | +133.27% | 15.92B | |
| +0.32% | +0.58% | +14.00% | +19.59% | 13.86B | |
| +3.30% | +0.76% | +90.23% | +99.12% | 13.52B | |
| Average | +1.96% | +5.82% | +79.44% | +120.52% | 27.3B | |
| Weighted average by Cap. | +2.07% | +6.53% | +90.20% | +137.91% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 195K 170K 157K 146K 277K 18.57M 281K 1.88M 731K 9.13M 732K 716K 31.45M | 14.46M 12.65M 11.62M 10.83M 20.55M 1.38B 20.86M 140M 54.24M 677M 54.3M 53.13M 2.33B |
| Net income | -32.94M -28.79M -26.46M -24.67M -46.78M -3.14B -47.49M -318M -123M -1.54B -124M -121M -5.31B | -10.7M -9.36M -8.6M -8.02M -15.2M -1.02B -15.44M -103M -40.14M -501M -40.18M -39.32M -1.73B |
| Net Debt | -9.37M -8.19M -7.53M -7.02M -13.31M -892M -13.51M -90.39M -35.14M -439M -35.18M -34.42M -1.51B | 7.91M 6.92M 6.36M 5.93M 11.24M 753M 11.41M 76.32M 29.67M 370M 29.7M 29.06M 1.28B |
Employees
-
